The Global Flow Cytometry Market is Expected to Reach USD 11,016.73 Million by 2029, Growing at a CAGR of 11.2% in the Forecast Period of 2022 to 2029

In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million). In September 2020, according to ACS Journal, 19.3 million new cancer cases were recorded, with 9.9 million deaths through cancer (excluding non-melanoma).   

Access Full Report at  https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market

The global flow cytometry market is expected to reach USD 11,016.73 Million by 2029 from USD 4,741.84 Million in 2021, growing at a CAGR of 11.2% in the forecast period of 2022 to 2029. The increase in the adoption of flow cytometry in research and academia and wide development in pharmaceutical and biotechnology industries are expected to drive the market's growth. The developing pipeline of stem cell research and strategic initiatives by market players are expected to provide an opportunity to enhance the treatment.

Flow Cytometry Market

The increasing prevalence of chronic diseases across the world will drive the market's growth rate

The increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The rising incidence of diseases increases the global market as many companies invest in research and development. This resulted in the huge lead in demand for advancements to diagnose the disease through quick and accurate techniques. Hence, the rising prevalence of chronic diseases and the growing demand for advanced diagnostic techniques can aid the numerous research studies for the market's rapid growth.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank and Others), Distribution Channel (Direct Tenders and Retail Sales)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Luminex Corporation (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Cytek Biosciences (U.S.), bioMérieux SA (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories (U.S.) among others.             

Data Points Covered in the Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The global flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.

  • On the basis of product, the global flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services. In 2022, the reagents and consumables segment is expected to dominate the global flow cytometry market with a 58.22% market share due to rising technological advancement and it's wide use in research by academic and research institutes and pharmaceuticals and biotechnology companies.
  • On the basis of technology, the global flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry. In 2022, the cell-based flow cytometry segment is expected to dominate the global flow cytometry market with a 64.04% market share due to the rising prevalence of infectious diseases and the requirement of specific cell-based diagnoses for timely treatment options.
  • On the basis of application, the global flow cytometry market is segmented into research applications, clinical applications, and industrial applications. In 2022, the research applications segment is expected to dominate the global flow cytometry market with a 55.05% market share due to the rising number of pharmaceutical and biotechnology companies in the region's developing countries and increasing government funds for significant research studies.
  • On the basis of end user, the global flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others. In 2022, the academic & research institutes segment is expected to dominate the global flow cytometry market with a 34.98% market share as flow cytometry is widely used in research for FACS fluorescence-activated single-cell sorting, cell cycle analysis, and apoptosis assays, among others.

The pharmaceutical & biotechnology companies segment will dominate the end user segment of the flow cytometry market

The pharmaceutical & biotechnology companies segment will emerge as the dominating segment under end user with approximately 35.00% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the IT industry all around the globe will further bolster the growth of this segment.

  • On the basis of distribution channel, the global flow cytometry market is segmented into direct tenders and retail sales. In 2022, the retail sales segment is expected to dominate the global flow cytometry market with a 55.01% market share as they provide high-quality products through various supply models and distributors with enhanced measures even during lockdowns.

The retail sales segment will dominate the distribution channel segment of the flow cytometry market

The retail sales segment will emerge as the dominating segment distribution channel segment. This is because of the growing number of retailers in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.

Major Players

Data Bridge Market Research recognizes the following companies as the market players in flow cytometry market: Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Luminex Corporation (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Cytek Biosciences (U.S.), bioMérieux SA (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories (U.S.).

Flow Cytometry Market

Market Development

  • In June 2021, Bio-Rad launched Three StarBright Dyes for multicolor flow cytometry panels to improve brightness, precise excitation, and emission spectra that help in market technological advancements
  • In December 2020, Apogee Flow Systems Ltd. launched their new cooling system and faster motor drivers for Apogee Flow's 96 well microplate auto-sampler. The cooler reduces the microplate temperature, thereby increasing sample stability during analysis, and drivers are enabled to operate at a higher speed to reduce the time between samples

Regional Analysis

Geographically, the countries covered in the flow cytometry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in the flow cytometry market during the forecast period 2022 - 2029

North America is expected to dominate the global flow cytometry market due to the technological advancement and growing adoption of various advanced diagnostic applications.

Asia-Pacific is estimated to be the fastest growing region in the flow cytometry market the forecast period 2022 - 2029

Asia-Pacific is likely to be the fastest-growing region in the global market owing to the developing healthcare infrastructure.

COVID-19 Impact

According to an interview with Thermo Fisher Scientific (US) scientists, the University of California requested participants for a significant project researching the impacts of SARS-CoV-2 from researchers, nurses, and doctors. Using other flow cytometry analyzers, such as the Attune NxT Flow Cytometer, the researchers analyzed blood samples using purified proteins and antibody panels. Since several COVID-19 research projects use flow cytometry technologies to examine how the immune system responds to SARS-CoV-2, the COVID-19 pandemic has thus had a favorable effect on this industry.

For more detailed information about the flow cytometry on market report, click here – https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market